Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
American Journal of Clinical Oncology
|
June 1, 1986
Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP
R T Eagan, S Frytak, E T Creagan, et al.
Cancer Treatment Reports
|
August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung
R T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports
|
May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers
R T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology
|
April 1, 1987
No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
Cancer Treatment Reports
|
September 1, 1979
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung
R T Eagan, S Frytak, E T Creagan, et al.
Journal of Neuro-Oncology
|
January 1, 1987
Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors
R T Eagan, R P Dinapoli, T L Cascino, et al.
Cancer Treatment Reports
|
September 1, 1976
A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas
E T Creagan, R G Hahn, D L Ahmann, et al.
Medical and Pediatric Oncology
|
January 1, 1978
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomas
E T Creagan, J H Edmonson, R G Hahn, et al.
Oncology
|
January 1, 1981
Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors
R T Eagan, E T Creagan, H F Bisel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1994
Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases
E G Shaw, J Q Su, R T Eagan, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
American Journal of Clinical Oncology
|
June 1, 1986
Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP
R T Eagan, S Frytak, E T Creagan, et al.
Cancer Treatment Reports
|
August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung
R T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports
|
May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers
R T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology
|
April 1, 1987
No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
Cancer Treatment Reports
|
September 1, 1979
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung
R T Eagan, S Frytak, E T Creagan, et al.
Journal of Neuro-Oncology
|
January 1, 1987
Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors
R T Eagan, R P Dinapoli, T L Cascino, et al.
Cancer Treatment Reports
|
September 1, 1976
A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas
E T Creagan, R G Hahn, D L Ahmann, et al.
Medical and Pediatric Oncology
|
January 1, 1978
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomas
E T Creagan, J H Edmonson, R G Hahn, et al.
Oncology
|
January 1, 1981
Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors
R T Eagan, E T Creagan, H F Bisel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1994
Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases
E G Shaw, J Q Su, R T Eagan, et al.
Page
of 12